Literature DB >> 16785758

Problems associated with the 25-gauge transconjunctival sutureless vitrectomy system during and after surgery.

Suk Ho Byeon1, Young Kwang Chu, Sung Chul Lee, Hyoung Jun Koh, Sung Soo Kim, Oh Woong Kwon.   

Abstract

OBJECTIVE: To report the initial experiences with the 25-gauge transconjunctival sutureless vitrectomy (TSV) system, including intraoperative and postoperative problems.
METHODS: We retrospectively reviewed the medical records and surgical videotapes of 50 consecutive patients who underwent vitrectomy performed by one surgeon using the TSV system.
RESULTS: Intraoperatively, we encountered such problems as difficulty in inserting the microcannula, which led to deformity, instability of the microcannula, self-disconnection of the infusion tip and resultant lens damage, and conversion to 20-gauge conventional vitrectomy. Postoperatively, there were 8 cases with hypotony (IOP < 6 mm Hg) on day 1, 6 cases with elevated IOP, and 3 cases with retinal detachment during follow-up.
CONCLUSION: Though certain problems exist during and after surgeries using TSV, this system is both convenient and safe for various vitreoretinal procedures.

Entities:  

Mesh:

Year:  2006        PMID: 16785758     DOI: 10.1159/000093081

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  20 in total

1.  Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy.

Authors:  Mahmoud Mohamed Farouk; Takeshi Naito; Khulood Mohammed Sayed; Toshihiko Nagasawa; Takashi Katome; Gamal Radwan; Ahmad Abdallah; Mohamed Elagouz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-17       Impact factor: 3.117

2.  A new infusion sustainer that stabilizes perfusion during sutureless 25-gauge vitrectomy.

Authors:  Takayuki Hattori; Hiroyuki Shimada; Hiroyuki Nakashizuka; Ryusaburo Mori; Yoshihiro Mizutani; Mitsuko Yuzawa
Journal:  Int Ophthalmol       Date:  2010-04-02       Impact factor: 2.031

3.  [Three-dimensional visualization of sclerotomies with ultrasound biomicroscopy. Comparison of 20 and 23 gauge incisions on the porcine eyeball].

Authors:  V Witte; E Berger; R Guthoff; O Stachs
Journal:  Ophthalmologe       Date:  2011-07       Impact factor: 1.059

4.  Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment.

Authors:  M S Dikopf; K H Patel; V J Setlur; J I Lim
Journal:  Eye (Lond)       Date:  2015-07-17       Impact factor: 3.775

5.  Modified incision in 25-gauge vitrectomy in the creation of a tunneled airtight sclerotomy: an ultrabiomicroscopic study.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Andrea Vento; Sofia Miniaci; Federica Cresti; Michele Palla
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-21       Impact factor: 3.117

6.  Adverse events after pars plana vitrectomy among medicare beneficiaries.

Authors:  Joshua D Stein; David N Zacks; Daniel Grossman; Hilary Grabe; Mark W Johnson; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-12

7.  Comparative outcomes of pars plana vitrectomy in acute postoperative endophthalmitis with 25-gauge and 20-gauge techniques.

Authors:  Tugrul Altan; Ziya Kapran; Ilker Eser; Nur Acar; Yaprak Banu Unver; Serap Yurttaser
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

8.  [Long-term results after pars plana vitrectomy with 25 gauge technique].

Authors:  A Lommatzsch; B Heimes; M Trieschmann; G Spital; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

9.  Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection.

Authors:  Tansu Erakgun; Sait Egrilmez
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

10.  Differences between the combination of the 25-gauge vitrectomy with phacoemulsification versus 20-gauge vitrectomy and phacofragmentation.

Authors:  Pere Romero-Aroca; Matias Almena-Garcia; Marc Baget-Bernaldiz; Juan Fernández-Ballart; Isabel Méndez-Marin; Angel Bautista-Perez
Journal:  Clin Ophthalmol       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.